Status:
COMPLETED
Drug Use Investigation Of Varenicline (Regulatory Post Marketing Commitment Plan)
Lead Sponsor:
Pfizer
Conditions:
Smoking Cessation
Eligibility:
All Genders
Brief Summary
The objective of this surveillance is to collect information about 1) adverse drug reaction not expected from the LPD (unknown adverse drug reaction), 2) the incidence of adverse drug reactions in thi...
Detailed Description
All the patients whom an investigator prescribes the first Varenicline(Champix) should be registered consecutively until the number of subjects reaches target number in order to extract patients enrol...
Eligibility Criteria
Inclusion
- Patients need to be administered Varenicline(Champix) in order to be enrolled in the surveillance.
Exclusion
- Patients not administered Varenicline(Champix).
Key Trial Info
Start Date :
February 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
3939 Patients enrolled
Trial Details
Trial ID
NCT00772941
Start Date
February 1 2009
End Date
December 1 2012
Last Update
February 28 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.